(Q46772702)

25 December 2017

title

Prevention of lung cancer progression by bexarotene in mouse models (English)

1 reference

25 December 2017

author name string

Wang Y

1

1 reference

25 December 2017

Zhang Z

2

1 reference

25 December 2017

Yao R

3

1 reference

25 December 2017

Jia D

4

1 reference

25 December 2017

Wang D

5

1 reference

25 December 2017

Lubet RA

6

1 reference

25 December 2017

You M

7

1 reference

25 December 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

25 December 2017

published in

Oncogene

1 reference

25 December 2017

volume

25

1 reference

25 December 2017

issue

9

1 reference

25 December 2017

page(s)

1320-1329

1 reference

25 December 2017

Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Lung cancer and smoking trends in the United States over the past 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

p53: at the crossroads of molecular carcinogenesis and molecular epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

LOH of chromosome 12p correlates with Kras2 mutation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

The RXR heterodimers and orphan receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

A novel constitutive androstane receptor-mediated and CYP3A-independent pathway of bile acid detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Molecular genetics of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Lung tumors in strain A mice as a bioassay for carcinogenicity of environmental chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Lung carcinoma in former smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Wildtype Kras2 can inhibit lung carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

7 January 2021

Initial clinical trial of a selective retinoid X receptor ligand, LGD1069

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

7 January 2021

Central hypothyroidism associated with retinoid X receptor-selective ligands

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

7 January 2021

Preclinical and clinical models of lung cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209180

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209180

1 reference

25 December 2017

1 reference

25 December 2017